THIS STORY HAS BEEN FORMATTED FOR EASY PRINTING

Businesses uneasy without Kennedy

Health, tech firms relied on senator

WHAT WILL BE MISSED Genzyme CEO Henri A. Termeer noted Kennedy’s support of innovation. WHAT WILL BE MISSED
Genzyme CEO Henri A. Termeer noted Kennedy’s support of innovation.
By Robert Gavin and Liz Kowalczyk
Globe Staff / September 1, 2009

E-mail this article

Invalid E-mail address
Invalid E-mail address

Sending your article

Your article has been sent.

Text size +

The death of Senator Edward M. Kennedy is raising concerns about the future of programs he championed that benefited the state’s major employers, particularly in the fields of health care, higher education, and technology. (Full article: 1077 words)

This article is available in our archives:

Globe Subscribers

FREE for subscribers

Subscribers to the Boston Globe get unlimited access to our archives.

Not a subscriber?

Non-Subscribers

Purchase an electronic copy of the full article. Learn More

  • $9.95 1 month archives pass
  • $24.95 3 months archives pass
  • $74.95 1 year archives pass